Declotting Devices Market Seen Reaching $3.1 Billion by 2030

The declotting devices market is projected to grow from $2.26 billion in 2025 to $2.41 billion in 2026, then reach $3.1 billion by 2030. Rising vascular disease, greater use of minimally invasive procedures, and stronger demand for mechanical thrombectomy are driving the outlook.

Why it matters: - Declotting devices are used to remove blood clots and restore circulation in urgent cases such as deep vein thrombosis and pulmonary embolism. - Growing clot-related disease burden is increasing demand for faster vascular intervention tools. - The market’s projected expansion signals more adoption of mechanical clot-removal technologies in hospitals and specialty centers.

What happened: - The Business Research Company released a declotting devices market report covering market size, trends, segments, and regional growth through 2035. - The report values the global market at $2.26 billion in 2025. - The market is expected to reach $2.41 billion in 2026. - The report projects the market will rise to $3.1 billion by 2030. - The forecast implies a 6.6% compound annual growth rate from 2025 through 2030. - North America held the largest share of the global market in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - Download a free sample of the report. - View the full market report.

The details: - The report links earlier growth to rising cases of deep vein thrombosis and pulmonary embolism. - Greater awareness of clot-related health risks also supported demand. - More vascular emergency interventions contributed to market expansion. - Hospital-based interventional services expanded over the same period. - Mechanical declotting methods have shown better clinical results, which helped adoption. - Future growth is expected from higher rates of cardiovascular and thrombotic disease. - Demand for urgent emergency procedures is also expected to rise. - Wider use of minimally invasive vascular techniques should support sales. - Growth in interventional radiology and cardiology centers is another expected driver. - Improved access to advanced thrombectomy devices is expected to help the market advance. - Key trends include a stronger preference for mechanical thrombectomy over drug-based techniques. - Faster clot removal in emergencies is becoming a bigger priority. - Treatment of acute vascular disorders is expanding. - Precision and safety in thrombus extraction are getting more attention. - The report says vascular disorders are rising because of obesity, inactivity, and an aging global population. - The National Institutes of Health reported in January 2025 that the global financial burden of stroke exceeds US$890 billion annually. - The NIH said stroke costs represent about 0.66% of global GDP and could nearly double by 2050.

Between the lines: - The market outlook reflects a shift toward procedures that can restore blood flow quickly with less invasive methods. - Regional growth patterns suggest mature markets are still dominant, while developing healthcare systems are creating the next wave of demand. - The emphasis on safety and precision points to product competition around performance, not just availability.

What's next: - The market is expected to keep growing at the same 6.6% pace through 2030. - Asia-Pacific’s expansion will be a key indicator of how quickly advanced vascular care is spreading beyond established markets. - The report’s added scoring tools and forecasting dashboards are aimed at helping buyers and investors track hotspots and technology shifts. - The Business Research Company is also offering updated graphics, tables, TAM analysis, company scoring matrices, and future trend analysis in its 2026 reports.

The bottom line: - Declotting devices are moving from a niche interventional toolset to a broader growth market as clot-related disease rates rise and hospitals favor faster, more precise thrombectomy methods.